Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balsano

Showing results (241-250 of 408) with videos related to

Pageof 41
Sort By:
Liver|February 1, 1986
Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH)V Barnaba, M Levrero, A Franco, et al.
Circulation|July 1, 1990
Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile GroupF Balsano, P Rizzon, F Violi, et al.
Science (New York, N.Y.)|January 10, 1997
Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathwayG Natoli, A Costanzo, A Ianni, et al.
Acta Neurologica Scandinavica|October 1, 1989
Blood lipid peroxides in TIA: relation to platelet function and metabolic profileF Violi, C Alessandri, A Ghiselli, et al.
Virology|April 1, 1992
Characterization of the hepatitis B virus preS/S region encoded transcriptional transactivatorG Natoli, M L Avantaggiati, C Balsano, et al.
Stroke|October 1, 1988
Leukocyte response in patients suffering from acute strokeF Violi, M Rasura, C Alessandri, et al.
Oncogene|October 1, 1994
Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pXG Natoli, M L Avantaggiati, P Chirillo, et al.
Journal of Hepatology|January 1, 1986
Effect of 28 consecutive days lymphoblastoid interferon (alpha-IFN) administration on hepatitis B virus related chronic liver diseaseA Franco, V Barnaba, M Levrero, et al.
Clinical and Experimental Rheumatology|November 1, 1989
Anticardiolipin antibodies possess anticoagulant activity which is blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodiesG Valesini, F Violi, D Ferro, et al.
Archives of Virology. Supplementum|January 1, 1992
The hepatitis B virus X protein transactivation of c-fos and c-myc proto-oncogenes is mediated by multiple transcription factorsM L Avantaggiati, C Balsano, G Natoli, et al.
Pageof 41

Showing results (241-250 of 408) with videos related to

Sort By:
Pageof 41
Liver|February 1, 1986
Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH)V Barnaba, M Levrero, A Franco, et al.
Circulation|July 1, 1990
Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile GroupF Balsano, P Rizzon, F Violi, et al.
Science (New York, N.Y.)|January 10, 1997
Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathwayG Natoli, A Costanzo, A Ianni, et al.
Acta Neurologica Scandinavica|October 1, 1989
Blood lipid peroxides in TIA: relation to platelet function and metabolic profileF Violi, C Alessandri, A Ghiselli, et al.
Virology|April 1, 1992
Characterization of the hepatitis B virus preS/S region encoded transcriptional transactivatorG Natoli, M L Avantaggiati, C Balsano, et al.
Stroke|October 1, 1988
Leukocyte response in patients suffering from acute strokeF Violi, M Rasura, C Alessandri, et al.
Oncogene|October 1, 1994
Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pXG Natoli, M L Avantaggiati, P Chirillo, et al.
Journal of Hepatology|January 1, 1986
Effect of 28 consecutive days lymphoblastoid interferon (alpha-IFN) administration on hepatitis B virus related chronic liver diseaseA Franco, V Barnaba, M Levrero, et al.
Clinical and Experimental Rheumatology|November 1, 1989
Anticardiolipin antibodies possess anticoagulant activity which is blocked by a monoclonal antibody against a cross reacting idiotype of antiphospholipid antibodiesG Valesini, F Violi, D Ferro, et al.
Archives of Virology. Supplementum|January 1, 1992
The hepatitis B virus X protein transactivation of c-fos and c-myc proto-oncogenes is mediated by multiple transcription factorsM L Avantaggiati, C Balsano, G Natoli, et al.
Pageof 41